United States Oral Anticoagulants Market Report 2017

October 2017 | 102 pages | ID: UEA8C706CE4EN
QYResearch

Abstracts

In this report, the United States Oral Anticoagulants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Oral Anticoagulants in these regions, from 2012 to 2022 (forecast).

United States Oral Anticoagulants market competition by top manufacturers/players, with Oral Anticoagulants sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi
• Bristol-Myers Squibb
• Bayer
• Johnson & Johnson
• Aspen
• Boehringer Ingelheim
• Lilly
• Daiichi Sankyo
• Otsuka
• AstraZeneca

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• PAI
• LMWH
• DTI
• DFXa
• VKA
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• VTE
• ACS/MI
• AF
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Oral Anticoagulants Market Report 2017

1 ORAL ANTICOAGULANTS OVERVIEW

1.1 Product Overview and Scope of Oral Anticoagulants
1.2 Classification of Oral Anticoagulants by Product Category
  1.2.1 United States Oral Anticoagulants Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Oral Anticoagulants Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 PAI
  1.2.4 LMWH
  1.2.5 DTI
  1.2.6 DFXa
  1.2.7 VKA
  1.2.8 Others
1.3 United States Oral Anticoagulants Market by Application/End Users
  1.3.1 United States Oral Anticoagulants Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 VTE
  1.3.3 ACS/MI
  1.3.4 AF
  1.3.5 Others
1.4 United States Oral Anticoagulants Market by Region
  1.4.1 United States Oral Anticoagulants Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Oral Anticoagulants Status and Prospect (2012-2022)
  1.4.3 Southwest Oral Anticoagulants Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Oral Anticoagulants Status and Prospect (2012-2022)
  1.4.5 New England Oral Anticoagulants Status and Prospect (2012-2022)
  1.4.6 The South Oral Anticoagulants Status and Prospect (2012-2022)
  1.4.7 The Midwest Oral Anticoagulants Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Oral Anticoagulants (2012-2022)
  1.5.1 United States Oral Anticoagulants Sales and Growth Rate (2012-2022)
  1.5.2 United States Oral Anticoagulants Revenue and Growth Rate (2012-2022)

2 UNITED STATES ORAL ANTICOAGULANTS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Oral Anticoagulants Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Oral Anticoagulants Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Oral Anticoagulants Average Price by Players/Suppliers (2012-2017)
2.4 United States Oral Anticoagulants Market Competitive Situation and Trends
  2.4.1 United States Oral Anticoagulants Market Concentration Rate
  2.4.2 United States Oral Anticoagulants Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oral Anticoagulants Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ORAL ANTICOAGULANTS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Oral Anticoagulants Sales and Market Share by Region (2012-2017)
3.2 United States Oral Anticoagulants Revenue and Market Share by Region (2012-2017)
3.3 United States Oral Anticoagulants Price by Region (2012-2017)

4 UNITED STATES ORAL ANTICOAGULANTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Oral Anticoagulants Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Oral Anticoagulants Revenue and Market Share by Type (2012-2017)
4.3 United States Oral Anticoagulants Price by Type (2012-2017)
4.4 United States Oral Anticoagulants Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ORAL ANTICOAGULANTS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Oral Anticoagulants Sales and Market Share by Application (2012-2017)
5.2 United States Oral Anticoagulants Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ORAL ANTICOAGULANTS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oral Anticoagulants Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb
  6.2.2 Oral Anticoagulants Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bayer
  6.3.2 Oral Anticoagulants Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.2 Oral Anticoagulants Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Aspen
  6.5.2 Oral Anticoagulants Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Aspen Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Boehringer Ingelheim
  6.6.2 Oral Anticoagulants Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Boehringer Ingelheim Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Lilly
  6.7.2 Oral Anticoagulants Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Lilly Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Daiichi Sankyo
  6.8.2 Oral Anticoagulants Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Daiichi Sankyo Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Otsuka
  6.9.2 Oral Anticoagulants Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Otsuka Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 AstraZeneca
  6.10.2 Oral Anticoagulants Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AstraZeneca Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 ORAL ANTICOAGULANTS MANUFACTURING COST ANALYSIS

7.1 Oral Anticoagulants Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Anticoagulants

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oral Anticoagulants Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Anticoagulants Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ORAL ANTICOAGULANTS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Oral Anticoagulants Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Oral Anticoagulants Sales Volume Forecast by Type (2017-2022)
11.3 United States Oral Anticoagulants Sales Volume Forecast by Application (2017-2022)
11.4 United States Oral Anticoagulants Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oral Anticoagulants
Figure United States Oral Anticoagulants Market Size (K MT) by Type (2012-2022)
Figure United States Oral Anticoagulants Sales Volume Market Share by Type (Product Category) in 2016
Figure PAI Product Picture
Figure LMWH Product Picture
Figure DTI Product Picture
Figure DFXa Product Picture
Figure VKA Product Picture
Figure Others Product Picture
Figure United States Oral Anticoagulants Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Oral Anticoagulants by Application in 2016
Figure VTE Examples
Table Key Downstream Customer in VTE
Figure ACS/MI Examples
Table Key Downstream Customer in ACS/MI
Figure AF Examples
Table Key Downstream Customer in AF
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Oral Anticoagulants Market Size (Million USD) by Region (2012-2022)
Figure The West Oral Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Oral Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Oral Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Oral Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Oral Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Oral Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Anticoagulants Sales (K MT) and Growth Rate (2012-2022)
Figure United States Oral Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Anticoagulants Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Oral Anticoagulants Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Oral Anticoagulants Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Anticoagulants Sales Share by Players/Suppliers
Figure 2017 United States Oral Anticoagulants Sales Share by Players/Suppliers
Figure United States Oral Anticoagulants Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Oral Anticoagulants Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Oral Anticoagulants Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Anticoagulants Revenue Share by Players/Suppliers
Figure 2017 United States Oral Anticoagulants Revenue Share by Players/Suppliers
Table United States Market Oral Anticoagulants Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Oral Anticoagulants Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Oral Anticoagulants Market Share of Top 3 Players/Suppliers
Figure United States Oral Anticoagulants Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oral Anticoagulants Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oral Anticoagulants Product Category
Table United States Oral Anticoagulants Sales (K MT) by Region (2012-2017)
Table United States Oral Anticoagulants Sales Share by Region (2012-2017)
Figure United States Oral Anticoagulants Sales Share by Region (2012-2017)
Figure United States Oral Anticoagulants Sales Market Share by Region in 2016
Table United States Oral Anticoagulants Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Oral Anticoagulants Revenue Share by Region (2012-2017)
Figure United States Oral Anticoagulants Revenue Market Share by Region (2012-2017)
Figure United States Oral Anticoagulants Revenue Market Share by Region in 2016
Table United States Oral Anticoagulants Price (USD/MT) by Region (2012-2017)
Table United States Oral Anticoagulants Sales (K MT) by Type (2012-2017)
Table United States Oral Anticoagulants Sales Share by Type (2012-2017)
Figure United States Oral Anticoagulants Sales Share by Type (2012-2017)
Figure United States Oral Anticoagulants Sales Market Share by Type in 2016
Table United States Oral Anticoagulants Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Oral Anticoagulants Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Anticoagulants by Type (2012-2017)
Figure Revenue Market Share of Oral Anticoagulants by Type in 2016
Table United States Oral Anticoagulants Price (USD/MT) by Types (2012-2017)
Figure United States Oral Anticoagulants Sales Growth Rate by Type (2012-2017)
Table United States Oral Anticoagulants Sales (K MT) by Application (2012-2017)
Table United States Oral Anticoagulants Sales Market Share by Application (2012-2017)
Figure United States Oral Anticoagulants Sales Market Share by Application (2012-2017)
Figure United States Oral Anticoagulants Sales Market Share by Application in 2016
Table United States Oral Anticoagulants Sales Growth Rate by Application (2012-2017)
Figure United States Oral Anticoagulants Sales Growth Rate by Application (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Oral Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Oral Anticoagulants Sales Growth Rate (2012-2017)
Figure Sanofi Oral Anticoagulants Sales Market Share in United States (2012-2017)
Figure Sanofi Oral Anticoagulants Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Oral Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Oral Anticoagulants Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Oral Anticoagulants Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Oral Anticoagulants Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Oral Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer Oral Anticoagulants Sales Growth Rate (2012-2017)
Figure Bayer Oral Anticoagulants Sales Market Share in United States (2012-2017)
Figure Bayer Oral Anticoagulants Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Oral Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Oral Anticoagulants Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Oral Anticoagulants Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Oral Anticoagulants Revenue Market Share in United States (2012-2017)
Table Aspen Basic Information List
Table Aspen Oral Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Aspen Oral Anticoagulants Sales Growth Rate (2012-2017)
Figure Aspen Oral Anticoagulants Sales Market Share in United States (2012-2017)
Figure Aspen Oral Anticoagulants Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Oral Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Oral Anticoagulants Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Oral Anticoagulants Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Oral Anticoagulants Revenue Market Share in United States (2012-2017)
Table Lilly Basic Information List
Table Lilly Oral Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Lilly Oral Anticoagulants Sales Growth Rate (2012-2017)
Figure Lilly Oral Anticoagulants Sales Market Share in United States (2012-2017)
Figure Lilly Oral Anticoagulants Revenue Market Share in United States (2012-2017)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Oral Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Oral Anticoagulants Sales Growth Rate (2012-2017)
Figure Daiichi Sankyo Oral Anticoagulants Sales Market Share in United States (2012-2017)
Figure Daiichi Sankyo Oral Anticoagulants Revenue Market Share in United States (2012-2017)
Table Otsuka Basic Information List
Table Otsuka Oral Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Otsuka Oral Anticoagulants Sales Growth Rate (2012-2017)
Figure Otsuka Oral Anticoagulants Sales Market Share in United States (2012-2017)
Figure Otsuka Oral Anticoagulants Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Oral Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AstraZeneca Oral Anticoagulants Sales Growth Rate (2012-2017)
Figure AstraZeneca Oral Anticoagulants Sales Market Share in United States (2012-2017)
Figure AstraZeneca Oral Anticoagulants Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Anticoagulants
Figure Manufacturing Process Analysis of Oral Anticoagulants
Figure Oral Anticoagulants Industrial Chain Analysis
Table Raw Materials Sources of Oral Anticoagulants Major Players/Suppliers in 2016
Table Major Buyers of Oral Anticoagulants
Table Distributors/Traders List
Figure United States Oral Anticoagulants Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Oral Anticoagulants Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Oral Anticoagulants Price (USD/MT) Trend Forecast (2017-2022)
Table United States Oral Anticoagulants Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Oral Anticoagulants Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Oral Anticoagulants Sales Volume (K MT) Forecast by Type in 2022
Table United States Oral Anticoagulants Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Oral Anticoagulants Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Oral Anticoagulants Sales Volume (K MT) Forecast by Application in 2022
Table United States Oral Anticoagulants Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Oral Anticoagulants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Anticoagulants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Anticoagulants Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources